Page 30 - 《中国药房》2024年8期
P. 30

综上所述,Auc能抑制乳腺癌细胞的增殖、侵袭和迁                             YIN H,LUO Q H,YIN H,et al. Aucubin inhibits the pro‐
          移,诱导细胞周期阻滞,抑制 EMT 进程,该作用可能与                              liferation and migration of cervical cancer cells by activa-
          抑制 CDK1/CCNB1/PLK1 信号通路激活有关。本研究                          ting miR-1294/YWHAZ signaling pathway[J]. J Med Res,
          基于 CDK1/CCNB1/PLK1 信号通路初步探讨了 Auc 对                       2023,52(4):53-58.
          乳腺癌细胞恶性生物学行为的影响,但乳腺癌病理机制                            [10]  方依寒,赵毅. 乳腺癌临床治疗与生殖保护相关问题[J].
          复杂,具体机制仍需进一步探讨。                                          中国实用外科杂志,2019,39(8):864-867.
          参考文献                                                     FANG Y H,ZHAO Y. Problems related to clinical treat‐
                                                                   ment and reproductive protection of breast cancer[J]. Chin
          [ 1 ]  刘军兰 . 乳腺癌首次成为全球最常见的癌症[J/OL]. 中                    J Pract Surg,2019,39(8):864-867.
               华乳腺病杂志(电子版),2020,14(6):389[2023-09-17].        [11]  梅凡,姚峰,朱磊,等. 桃叶珊瑚苷对肺癌细胞增殖、侵袭
               https://qikan. cqvip. com/Qikan/Article/Detail? id=710390-
                                                                   的抑制作用及对TGF-β1/SOX7通路的影响[J]. 湖北中医
               7778.DOI:10.3877/cma.j.issn.1674-0807.2020.06.013.  药大学学报,2021,23(4):10-14.
               LIU J L. Breast cancer has become the most common can‐  MEI F,YAO F,ZHU L,et al. Inhibitory effect of aucubin
               cer in the world for the first time[J/OL]. Chin J Breast Dis
                                                                   on the proliferation and invasion of lung cancer cells and
               Electron Ed,2020,14(6):389[2023-09-17]. https://qikan.  its effect on TGF-β1/SOX7 pathway[J]. J Hubei Univ Chin
               cqvip.com/Qikan/Article/Detail?id=7103907778.DOI:10.  Med,2021,23(4):10-14.
               3877/cma.j.issn.1674-0807.2020.06.013.
                                                              [12]  ZHENG K,HE Z D,KITAZATO K,et al. Selective au‐
          [ 2 ]  BRITT K L,CUZICK J,PHILLIPS K A. Key steps for ef‐  tophagy  regulates  cell  cycle  in  cancer  therapy[J].  Thera-
               fective breast cancer prevention[J]. Nat Rev Cancer,2020,  nostics,2019,9(1):104-125.
               20(8):417-436.                                 [13]  LIU J,PENG Y H,WEI W Y. Cell cycle on the crossroad
          [ 3 ]  朱志铭,任朝兴,马博. 桃叶珊瑚苷药理作用及分子机制
                                                                   of tumorigenesis and cancer therapy[J]. Trends Cell Biol,
               研究进展[J]. 生物加工过程,2021,19(5):482-490.                 2022,32(1):30-44.
               ZHU Z M,REN C X,MA B. Pharmacology and molecu‐  [14]  LÜÖND F,SUGIYAMA N,BILL R,et al. Distinct contri‐
               lar mechanism of aucubin:a review[J]. Chin J Bioprocess
                                                                   butions  of  partial  and  full  EMT  to  breast  cancer  malig‐
               Eng,2021,19(5):482-490.                             nancy[J]. Dev Cell,2021,56(23):3203-3221.e11.
          [ 4 ]  SHAO  M,KUANG  Z  Y,WANG  W  L,et  al.  Aucubin       [15]  REN  L W,YANG Y  H,LI W,et  al.  CDK1  serves  as  a
               exerts anticancer activity in breast cancer and regulates in‐
                                                                   therapeutic target of adrenocortical carcinoma via regula-
               testinal  microbiota[J].  Evid  Based  Complement  Alternat   ting epithelial-mesenchymal transition,G2/M phase transi‐
               Med,2022,2022:4534411.                              tion,and PANoptosis[J]. J Transl Med,2022,20(1):444.
          [ 5 ]  XING  Z  Y,WANG  X,LIU  J  Q,et  al.  Expression  and
                                                              [16]  LIU Y H,XU J,WANG Y N,et al. USP14 regulates cell
               prognostic  value  of  CDK1,CCNA2,and  CCNB1  gene   cycle  progression  through  deubiquitinating  CDK1  in
               clusters in human breast cancer[J]. J Int Med Res,2021,49  breast  cancer[J].  Acta  Biochim  Biophys  Sin,2022,54
              (4):300060520980647.                                (11):1610-1618.
          [ 6 ]  ZHOU  X,ZHAO  Q,XIAO  M.  Hsa_circ_0137652  regu‐
                                                              [17]  YU  Z  L,DENG  P,CHEN  Y  F,et  al.  Inhibition  of  the
               lates miR-1205/CCNB1 axis to accelerate the malignancy of   PLK1-coupled cell cycle machinery overcomes resistance
               breast cancer[J]. Mol Biotechnol,2023,65(11):1824-1835.
                                                                   to  oxaliplatin  in  colorectal  cancer[J].  Adv  Sci,2021,8
          [ 7 ]  WANG B Y,HUANG X T,LIANG H P,et al. PLK1 inhi‐
                                                                  (23):e2100759.
               bition  sensitizes  breast  cancer  cells  to  radiation  via  sup‐  [18]  ZHANG Z Z,CHENG L J,LI J,et al. Targeting Plk1 sen‐
               pressing  autophagy[J].  Int  J  Radiat  Oncol  Biol  Phys,  sitizes pancreatic cancer to immune checkpoint therapy[J].
               2021,110(4):1234-1247.
                                                                   Cancer Res,2022,82(19):3532-3548.
          [ 8 ]  王春晖,楚爱景,朱振宇,等. 雄黄外用对三阴性乳腺癌                   [19]  LU Y  B,YANG  G,XIAO Y,et  al.  Upregulated  cyclins
               上皮间质转化的调控作用研究[J]. 南京中医药大学学                          may be novel genes for triple-negative breast cancer based
               报,2022,38(11):1027-1034.
                                                                   on bioinformatic analysis[J]. Breast Cancer,2020,27(5):
               WANG C H,CHU A J,ZHU Z Y,et al. Study on the regu‐
                                                                   903-911.
               latory effect of realgar for external use on epithelial-  [20]  WU Y H,ZHOU T,QIAN D,et al. Z-guggulsterone in‐
               mesenchymal transformation in triple-negative breast cancer  duces cell cycle arrest and apoptosis by targeting the p53/
               [J]. J Nanjing Univ Tradit Chin Med,2022,38(11):1027-
                                                                   CCNB1/PLK1 pathway in triple-negative breast cancer[J].
               1034.                                               ACS Omega,2023,8(2):2780-2792.
          [ 9 ]  尹恒,罗全慧,殷浩,等. 桃叶珊瑚苷通过活化miR-1294/
                                                                            (收稿日期:2023-10-07  修回日期:2024-03-05)
               YWHAZ信号通路抑制宫颈癌细胞的增殖和迁移[J]. 医
                                                                                                  (编辑:张元媛)
               学研究杂志,2023,52(4):53-58.





          · 924 ·    China Pharmacy  2024 Vol. 35  No. 8                               中国药房  2024年第35卷第8期
   25   26   27   28   29   30   31   32   33   34   35